The UK economy has provided a relatively supportive backdrop for the consumer over the past year, who have benefitted from jobs growth, cheaper oil, and a near-zero inflationary environment.
Globally, approximately $5.5trn of bonds trade with negative yields and nearly one quarter of the world's GDP comes from countries with negative interest rates.
The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.
Stronger than 2015
Tech not immune from growth concerns
Gap in GDP growth between India and Brazil increases
Regulation is not helping
Morgan Stanley and Baillie Gifford discuss